Syra Health Corp.
SYRA
$0.10
-$0.0069-6.46%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.04% | 44.73% | 35.47% | 25.18% | 3.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.04% | 44.73% | 35.47% | 25.18% | 3.72% |
| Cost of Revenue | 33.45% | 51.19% | 26.89% | 12.85% | -8.33% |
| Gross Profit | 31.86% | 25.91% | 71.04% | 85.05% | 67.25% |
| SG&A Expenses | -2.18% | 22.04% | 47.24% | 48.54% | 40.00% |
| Depreciation & Amortization | 14.92% | 28.22% | 45.49% | 43.57% | 87.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.92% | 39.80% | 45.93% | 37.77% | 17.45% |
| Operating Income | 21.45% | -30.38% | -69.83% | -66.15% | -51.76% |
| Income Before Tax | 22.64% | -27.94% | -66.30% | -63.83% | -51.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.64% | -27.94% | -66.30% | -63.83% | -51.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.64% | -27.94% | -66.30% | -63.83% | -51.22% |
| EBIT | 21.45% | -30.38% | -69.83% | -66.15% | -51.76% |
| EBITDA | 21.96% | -30.41% | -69.84% | -66.06% | -50.94% |
| EPS Basic | 44.03% | 9.83% | -14.73% | -17.91% | -0.94% |
| Normalized Basic EPS | 44.06% | 9.87% | -14.70% | -17.85% | -0.93% |
| EPS Diluted | 44.03% | 9.83% | -14.73% | -17.91% | -0.94% |
| Normalized Diluted EPS | 44.06% | 9.87% | -14.70% | -17.85% | -0.93% |
| Average Basic Shares Outstanding | 63.36% | 55.17% | 46.53% | 32.45% | 34.18% |
| Average Diluted Shares Outstanding | 63.36% | 55.17% | 46.53% | 32.45% | 34.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |